# Dendrobium Huoshanense Suppository in Rectal Cancer

> **NCT05079438** · PHASE3 · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 168 (estimated)

## Conditions studied

- Locally Advanced Rectal Cancer

## Interventions

- **DRUG:** Dendrobium Huoshanense Suppository

## Key facts

- **NCT ID:** NCT05079438
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-07
- **Primary completion:** 2023-07-30
- **Final completion:** 2024-08-31
- **Target enrollment:** 168 (ESTIMATED)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05079438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05079438, "Dendrobium Huoshanense Suppository in Rectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05079438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*